abusesaffiliationarrow-downarrow-leftarrow-rightarrow-upattack-typeburgerchevron-downchevron-leftchevron-rightchevron-upClock iconclosedeletedevelopment-povertydiscriminationdollardownloademailenvironmentexternal-linkfacebookfiltergenderglobegroupshealthC4067174-3DD9-4B9E-AD64-284FDAAE6338@1xinformation-outlineinformationinstagraminvestment-trade-globalisationissueslabourlanguagesShapeCombined Shapeline, chart, up, arrow, graphLinkedInlocationmap-pinminusnewsorganisationotheroverviewpluspreviewArtboard 185profilerefreshIconnewssearchsecurityPathStock downStock steadyStock uptagticktooltiptwitteruniversalityweb
Article

11 Nov 2004

Author:
Sarah Bosely, Guardian [UK]

Tests lead to recall of cheap Aids drugs - Indian manufacturer's decision is a blow to Africa's anti-HIV battle

The campaign to get cheap Aids drugs to millions of Africans was dealt a blow yesterday when a manufacturer in India [Ranbaxy] admitted it could not prove the quality of its medicines and withdrew them from the list approved by the World Health Organisation. [also refers to Cipla]